<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02442518</url>
  </required_header>
  <id_info>
    <org_study_id>1837</org_study_id>
    <nct_id>NCT02442518</nct_id>
  </id_info>
  <brief_title>Antenatal Diagnosis of Placental Attachment Disorders</brief_title>
  <acronym>ADoPAD</acronym>
  <official_title>Antenatal Diagnosis of Placental Attachment Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NICOLA FRATELLI</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Ospedaliera San Gerardo di Monza</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS Burlo Garofolo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero-Universitaria di Parma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ARNAS Civico di Cristina Benefratelli, Palermo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Policlinico Universitario Agostino Gemelli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Città della Salute e della Scienza di Torino</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Valduce, Como</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Bolognini di Seriate Bergamo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Università degli Studi di Brescia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The accuracy of sonographic prenatal detection of invasive placentation is unclear. The
      objective of this prospective, multicenter, observational study is to assess the performance
      of ultrasound for prenatal identification of invasive placentation in women with placenta
      previa.

      This study involves more than 25 hospitals in Italy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Morbidly adherent placenta is a spectrum of conditions characterized by an
      abnormal adherence of the placenta to the implantation site. Three major variants of adherent
      placentation can be recognized according to the degree of trophoblastic invasion through the
      myometrium and the uterine serosa: placenta accreta, placenta increta and placenta percreta.
      All varieties of invasive placentation are associated with a significant increase in maternal
      morbidity.Placenta previa and previous uterine surgery represent the major risk factors for
      invasive placentation. Prenatal diagnosis of invasive placentation is associated with a
      reduced risk of maternal complications such as peripartum blood loss, need for transfusions
      and rate of hysterectomy, as it allows a preplanned treatment of the condition, however the
      performance of antenatal ultrasound and of different sonographic signs is not consistent
      across published studies because of limited sample size, retrospective design, variability of
      inclusion criteria and definition of invasive placentation.

      Objectives: The aim of this study is to systematically assess the performance of ultrasound
      in the prenatal diagnosis of placenta accreta and its variants and to evaluate the role of
      the different specific ultrasound signs in predicting disorders of invasive placentation. The
      sonographic signs assessed in this study were: (1) vascular lacunae within the placenta, (2)
      loss of normal hypoechoic retroplacental zone, (3) interruption of the bladder line and/or
      focal exophytic masses extending into the bladder space, considered together and labeled as
      'abnormalities of the uterus - bladder interface.

      Design:prospective, multicenter, observational study of pregnant women with placenta previa.

      Methods: The investigators hypothesized that ultrasound has a sensitivity of at least 80% and
      a specificity of at least 97%, with 10% confidence intervals, for antenatal diagnosis of
      invasive placentation.The investigators would require 2048 women with placenta previa, of
      whom approximately 61 (3%) will have morbidly adherent placenta, to test the null hypothesis
      with a 0.05 risk of type I error (alpha). Supposing a 10% of women with incomplete follow up
      the investigators aim to enroll 2254 women in this study.

      Diagnostic criteria that suggested placenta accreta, increta, or percreta included one or
      more of the following situations: (1) obliteration of the clear space, defined as the
      obliteration of any part of the echolucent area located between the uterus and placenta; (2)
      visualization of placental lacunae, defined as multiple linear, irregular vascular spaces
      within the placenta; and (3) interruption of the posterior bladder wall-uterine interface
      such that the usual continuous echolucent line appears instead as a series of dashes.

      The degree of placental invasion was defined as follows: (i) placenta accreta was assumed
      when placental 'cones' disrupted the decidual zone with mildly increased vascularization
      around these cones ; (ii) placenta increta was diagnosed when placental invasion into the
      myometrium was sonographically suspected as a result of the presence of irregular and diffuse
      demarcation of the placental - uterine wall interface and thinning of the myometrium that was
      overlying the placental - myometrial tissue. Placenta increta was also characterized by
      increased vascularization and irregularly shaped intraplacental vascular lacunae, resembling
      the characteristic 'moth damage' appearance ; and (iii) the sonographic finding of placenta
      percreta was defined by a complete absence of the myometrium, with the placenta extending to
      the serosa, or beyond, including vascular breakthrough.In addition, placenta percreta was
      also characterized by massive subplacental hypervascularization, with vessels extending
      irregularly into the placental - myometrial tissue and with numerous large intraplacental
      lacunae.

      Clinical and histopathological assessment of placental invasion:

      Sonographic findings were compared with the clinical outcome during and after delivery and
      the histomorphological examination of the placenta, performed by pathologists experienced in
      obstetric histopathology, who were blinded to the sonographic findings.

      .............................................................................................
      .............

      Main Outcomes measure:

      Primary Outcome: sensitivity (SN), specificity(SP), positive likelihood ratio (LR+), negative
      likelihood ratio (LR - ) and diagnostic odds ratio (DOR) of antenatal ultrasound and
      different sonographic signs for in prediction of morbidly adherent placenta.

      Secondary Outcome: to evaluate whether the maximum degree of placental invasion (placenta
      accreta, increta or percreta) can be predicted with antenatal ultrasound.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>diagnostic accuracy of sonographic prenatal detection of invasive placentation</measure>
    <time_frame>clinical and histopathological assessment of placental invasion at delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>maximum degree of placental invasion</measure>
    <time_frame>clinical and histopathological assessment of placental invasion at delivery</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2254</enrollment>
  <condition>Placenta Accreta</condition>
  <condition>Placenta Previa</condition>
  <arm_group>
    <arm_group_label>women with placenta praevia</arm_group_label>
    <description>women with placenta previa diagnosed at antenatal ultrasound in the third trimester of pregnancy (lower placental edge within 20 mm from the internal os above 26 week's gestation)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>antenatal ultrasound</intervention_name>
    <description>Transabdominal and Transvaginal ultrasound examinations were performed in the third trimester (with some fluid in the bladder so that the uterine bladder interface could be evaluated well).</description>
    <arm_group_label>women with placenta praevia</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      histopathological samples from women with placenta previa diagnosed with ultrasound in the
      3rd trimester of pregnancy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        women with placenta previa diagnosed at antenatal ultrasound in the third trimester of
        pregnancy (lower placental edge within 20 mm from the internal os above 26 week's
        gestation)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Placenta previa diagnosed with ultrasound above 26 weeks' gestation (lower edge
             reached and/or overlapped the internal cervical os, or the lower edge was between 0.1
             and 20.0 mm from the internal cervical os)

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  prepartum bleeding or fetal distress requiring immediate emergency Cesarean section
             before the enrollment of the woman
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>NICOLA FRATELLI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>BRESCIA UNIVERSITY, SPEDALI CIVILI DI BRESCIA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>GIUSEPPE CALI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ARNAS Civico di Cristina Benefratelli</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>NICOLA FRATELLI, MD</last_name>
    <phone>+390303995340</phone>
    <email>nicola.fratelli@spedalicivili.brescia.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>FEDERICO PREFUMO, Phd</last_name>
    <phone>+390303995340</phone>
    <email>federico.prefumo@spedalicivili.brescia.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Azienda Ospedaliera San Gerardo di Monza</name>
      <address>
        <city>Monza</city>
        <state>MB</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>PATRIZIA VERGANI, MD</last_name>
      <email>patrizia.vergani@unimib.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brescia University, Spedali Civili Di Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>25131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NICOLA FRATELLI, MD</last_name>
      <phone>+390303995340</phone>
      <email>nicola.fratelli@spedalicivili.brescia.it</email>
    </contact>
    <contact_backup>
      <last_name>FEDERICO PREFUMO, Phd</last_name>
      <phone>+390303995340</phone>
      <email>federico.prefumo@spedalicivili.brescia.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>ARNAS CIVICO di Cristina Benefratelli</name>
      <address>
        <city>Palermo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GIUSEPPE CALI', MD</last_name>
      <email>pinocali13@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG. 2014 Jan;121(1):62-70; discussion 70-1. doi: 10.1111/1471-0528.12405. Epub 2013 Aug 7.</citation>
    <PMID>23924326</PMID>
  </reference>
  <reference>
    <citation>Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2012;7(12):e52893. doi: 10.1371/journal.pone.0052893. Epub 2012 Dec 27.</citation>
    <PMID>23300807</PMID>
  </reference>
  <reference>
    <citation>Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, Kelly TF, Moore TR, Resnik R. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010 Jan;115(1):65-9. doi: 10.1097/AOG.0b013e3181c4f12a.</citation>
    <PMID>20027036</PMID>
  </reference>
  <reference>
    <citation>Tan CH, Tay KH, Sheah K, Kwek K, Wong K, Tan HK, Tan BS. Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. AJR Am J Roentgenol. 2007 Nov;189(5):1158-63.</citation>
    <PMID>17954654</PMID>
  </reference>
  <reference>
    <citation>Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG. 2009 Apr;116(5):648-54. doi: 10.1111/j.1471-0528.2008.02037.x. Epub 2009 Feb 4.</citation>
    <PMID>19191778</PMID>
  </reference>
  <reference>
    <citation>Dilauro MD, Dason S, Athreya S. Prophylactic balloon occlusion of internal iliac arteries in women with placenta accreta: literature review and analysis. Clin Radiol. 2012 Jun;67(6):515-20. doi: 10.1016/j.crad.2011.10.031. Epub 2012 Jan 2. Review.</citation>
    <PMID>22218410</PMID>
  </reference>
  <reference>
    <citation>D'Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013 Nov;42(5):509-17. doi: 10.1002/uog.13194. Epub 2013 Oct 2. Review.</citation>
    <PMID>23943408</PMID>
  </reference>
  <reference>
    <citation>Chalubinski KM, Pils S, Klein K, Seemann R, Speiser P, Langer M, Ott J. Prenatal sonography can predict degree of placental invasion. Ultrasound Obstet Gynecol. 2013 Nov;42(5):518-24. doi: 10.1002/uog.12451. Epub 2013 Oct 9.</citation>
    <PMID>23471888</PMID>
  </reference>
  <reference>
    <citation>Oppenheimer L; MATERNAL FETAL MEDICINE COMMITTEE. Diagnosis and management of placenta previa. J Obstet Gynaecol Can. 2007 Mar;29(3):261-266. doi: 10.1016/S1701-2163(16)32401-X.</citation>
    <PMID>17346497</PMID>
  </reference>
  <reference>
    <citation>Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol. 2005 Jul;26(1):89-96. Review.</citation>
    <PMID>15971281</PMID>
  </reference>
  <reference>
    <citation>Calì G, Giambanco L, Puccio G, Forlani F. Morbidly adherent placenta: evaluation of ultrasound diagnostic criteria and differentiation of placenta accreta from percreta. Ultrasound Obstet Gynecol. 2013 Apr;41(4):406-12. doi: 10.1002/uog.12385.</citation>
    <PMID>23288834</PMID>
  </reference>
  <reference>
    <citation>Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem. 2003 Jan;49(1):1-6. Review.</citation>
    <PMID>12507953</PMID>
  </reference>
  <reference>
    <citation>Wortman AC, Alexander JM. Placenta accreta, increta, and percreta. Obstet Gynecol Clin North Am. 2013 Mar;40(1):137-54. doi: 10.1016/j.ogc.2012.12.002. Review.</citation>
    <PMID>23466142</PMID>
  </reference>
  <reference>
    <citation>Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J. 2003 Sep;20(5):453-8. Review. Erratum in: Emerg Med J. 2004 Jan;21(1):126.</citation>
    <PMID>12954688</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2015</study_first_submitted>
  <study_first_submitted_qc>May 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2015</study_first_posted>
  <last_update_submitted>December 14, 2015</last_update_submitted>
  <last_update_submitted_qc>December 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi di Brescia</investigator_affiliation>
    <investigator_full_name>NICOLA FRATELLI</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>placenta accreta</keyword>
  <keyword>placenta previa</keyword>
  <keyword>ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Previa</mesh_term>
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

